181 related articles for article (PubMed ID: 35245483)
1. Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia.
Zhou Q; Teng Y; Pan J; Shi Q; Liu Y; Zhang F; Liang D; Li Z; Wu L
Clin Chim Acta; 2022 Jun; 531():48-55. PubMed ID: 35245483
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
Gao S; Hu S; Duan H; Wang L; Kong X
BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.
Chear CT; Ismail IH; Chan KC; Noh LM; Kassim A; Latiff AHA; Gill SS; Ramly NH; Tan KK; Sundaraj C; Choo CM; Mohamed SAS; Baharin MF; Zamri AS; Yahya SNHS; Mohamad SB; Ripen AM
Front Immunol; 2023; 14():1252765. PubMed ID: 37809070
[TBL] [Abstract][Full Text] [Related]
4. Novel
Shaka Z; Mojtabavi H; Rayzan E; Zoghi S; Shahkarami S; Raul JH; Sedighi I; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2021; 49(2):80-83. PubMed ID: 33641298
[TBL] [Abstract][Full Text] [Related]
5. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
Front Immunol; 2020; 11():2001. PubMed ID: 33013854
[No Abstract] [Full Text] [Related]
6. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.
Zhang YN; Gao YY; Yang SD; Cao BB; Zheng KL; Wei P; Chen LF; Chen WX
BMC Neurol; 2019 Dec; 19(1):320. PubMed ID: 31830942
[TBL] [Abstract][Full Text] [Related]
7. [Gene diagnosis of X-linked agammaglobulinemia].
Wang XC; Wang Y; Kanegane H; Toshio M; Yu YH
Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):449-52. PubMed ID: 16053733
[TBL] [Abstract][Full Text] [Related]
8. Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.
Rivière JG; Franco-Jarava C; Martínez-Gallo M; Aguiló-Cucurull A; Blasco-Pérez L; Paramonov I; Antolín M; Martín-Nalda A; Soler-Palacín P; Colobran R
Front Immunol; 2020; 11():46. PubMed ID: 32117230
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients.
Qin X; Jiang LP; Tang XM; Wang M; Liu EM; Zhao XD
World J Pediatr; 2013 Aug; 9(3):273-7. PubMed ID: 23335184
[TBL] [Abstract][Full Text] [Related]
10. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
Kong X; Mo G; Liu N; Tian P; Chen M
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
[TBL] [Abstract][Full Text] [Related]
11. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
14. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
15. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
16. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
[TBL] [Abstract][Full Text] [Related]
17. A novel Bruton's tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia.
Zheng B; Zhang Y; Jin Y; Yu H
BMC Pediatr; 2014 Oct; 14():265. PubMed ID: 25316352
[TBL] [Abstract][Full Text] [Related]
18. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and BTK gene defect in 4 unrelated Taiwanese families with Bruton's disease.
Lee KH; Shyur SD; Chu SH; Huang LH; Kao YH; Lei WT; Cheng CH; Lo CY; Chen CK; Liu LC
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):260-5. PubMed ID: 22053596
[TBL] [Abstract][Full Text] [Related]
20. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
